Table 2 Pathway analysis of adipose subcutaneous tissue
Term name | Description | FDR value |
|---|---|---|
hsa04151 | PI3K-Akt signaling pathway | 1.57E−13 |
hsa04068 | FoxO signaling pathway | 3.76E−10 |
hsa05200 | Pathways in cancer | 7.15E−10 |
hsa04080 | Neuroactive ligand-receptor interaction | 1.03E−9 |
hsa04066 | HIF-1 signaling pathway | 1.62E−8 |
hsa04668 | TNF signaling pathway | 2.6E−8 |
hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 3.89E−8 |
hsa05205 | Proteoglycans in cancer | 4.8E−8 |
hsa04931 | Insulin resistance | 1.01E−7 |
hsa05418 | Fluid shear stress and atherosclerosis | 1.01E−7 |
hsa04920 | Adipocytokine signaling pathway | 1.1E−7 |
hsa05206 | MicroRNAs in cancer | 1.18E−7 |
hsa05163 | Human cytomegalovirus infection | 1.32E−7 |
hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.47E−7 |
hsa01521 | EGFR tyrosine kinase inhibitor resistance | 2.55E−7 |
hsa04015 | Rap1 signaling pathway | 2.55E−7 |